Lupus

Article	Citations
Distinctive cerebral small vessel disease patterns are associated with ischemic stroke in systemic lupus erythematosus	89
Small intestine necrosis in catastrophic antiphospholipid syndrome: A rare and severe case	60
FKN secreted by kidney epithelial cells regulates macrophage activation in lupus nephritis via the Hippo signaling pathway	54
Corrigendum to The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations	30
Long-term outcome of tacrolimus monotherapy in a patient with lupus nephritis: A 12-year observation	30
Cardiac involvement in systemic lupus erythematosus: Interest of 2D global longitudinal strain	29
The high expression of miR-564 in patients with systemic lupus erythematosus promotes differentiation and maturation of DC cells by negatively regulating TP53 expression in vitro	26
Evaluation of health literacy and its association with medication adherence and quality of life in childhood-onset systemic lupus erythematosus	25
Predictors for early readmission in patients hospitalized with new onset pediatric lupus nephritis	24
Intestinal involvement in lupus: From pathophysiology to therapeutic perspectives	24
Rituximab use in pediatric systemic lupus erythematosus: Indications, efficacy and safety in an Indian cohort	24
Characteristics and risk factors of retinal vasculopathy in antiphospholipid syndrome	24
A pharmacoeconomic study comparing the use of mycophenolate mofetil or cyclophosphamide as induction therapy in lupus nephritis patients in Egypt	22
Pregnancy in patients with systemic lupus erythematosus after cyclophosphamide therapy	22
LncRNA NRIR serves as a biomarker for systemic lupus erythematosus and participates in the disease progression	20
Associations between blood IL-33 levels and IL-33 gene polymorphisms with susceptibility to systemic lupus erythematosus: A meta-analysis	19
Pilot study on accelerated aging in lupus using epigenetic biomarkers of age	19
Immunohistochemical expression of perforin in adult systemic lupus erythematosus associated macrophage activation syndrome: Clinicohematological correlation and literature review	18
Systemic lupus international collaborating clinics-2012 and European league against rheumatism/American college of rheumatology-2019 classification criteria for systemic lupus erythematosus associated	18
Characteristics of SLE patients with symptomatic COVID-19: Single centre experience at Sultan Qaboos University Hospital over a 30-month period	18
Unchanged trend in mortality from systemic lupus erythematosus during the 2020 COVID-19 pandemic: A nationwide population-based study	17
Evaluation of survivin expression and regulating miRNAs of survivin expression in peripheral blood mononuclear cells in systemic lupus erythematous patients	17
Severe infections in patients with systemic lupus erythematosus from Tunisia: Prevalence and risk factors	16
Retrospective cohort study identifying pulmonary complications in a cohort of patients with systemic lupus erythematosus	16
Childhood adverse experiences and clinical manifestations in women with systemic lupus erythematosus	16

Cognitive dysfunction in patients with systemic lupus erythematosus. A cross-sectional study in a Brazilian sample	16
Positive psychological capital, post-traumatic growth, social support, and quality of life in patients with systemic lupus erythematosus: A cross-sectional study	16
Belimumab-induced periungual pyogenic granulomas: A case report	15
Clinicopathologic features in childhood-onset lupus nephritis with antineutrophil cytoplasmic antibody positivity——a multi-center retrospective study	15
High mobility group box protein 1 (HMGB1) serum and urinary levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus: A possible relation to lupus nephritis	15
Neonatal Fc receptor expression in lymphoid and myeloid cells in systemic lupus erythematosus	15
Air pollution influence on serum inflammatory interleukins: A prospective study in childhood-onset systemic lupus erythematous patients	15
The impact of pregnancy planning and medical readiness on reproductive outcomes in women with systemic lupus erythematosus	14
Symptomatic osteonecrosis of the hip and knee in patients with systemic lupus erythematosus: Prevalence, pattern, and comparison of natural course	14
Comparison of late-onset and non-late-onset systemic lupus erythematosus individuals in a real-world electronic health record cohort	14
Investigating how patients with lupus nephritis access and trust health information: Results from a Canadian survey of patients with lupus nephritis	14
Three functional variants in the NLRP3 gene are associated with susceptibility and clinical characteristics of systemic lupus erythematosus	14
Associations between physicians’ global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: A longitudinal study	13
Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients	13
Interest on the internet for systemic lupus erythematosus: Analysis of Google Trends in Latin American countries	13
The challenges in diagnosing pediatric primary antiphospholipid syndrome	13
Predictive factors of fetal and maternal pregnancy outcomes in Japanese patients with systemic lupus erythematosus	13
Long-term follow-up of autologous peripheral blood hematopoietic stem cell transplantation for refractory lupus nephritis—a series study of 20 patients	12
Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares	12
Pearls for the diagnosis and possible pathophysiological mechanisms of valproic acid-induced lupus erythematosus: A literature review	12
Treatment adherence and quality of life in colombian patients with lupus nephritis	11
Posterior reversible encephalopathy syndrome in juvenile lupus- a case series and literature review	11
Risk of Bloodstream Infection in Patients with Systemic Lupus Erythematosus Exposed to Prolonged Medium-to-High-Dose Glucocorticoids	11
Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE	11
Patient-reported disease impact of systemic lupus erythematosus with active joint symptoms: Results from the systemic lupus erythematosus-update survey	11
Parkinsonism as the presenting manifestation of lupus: A case-based review	11
Optical coherence tomography angiography findings of systemic lupus erythematosus patients and the effect of neuropsychiatric involvement on it	11
Lymphoid interstitial pneumonia in a patient with systemic lupus erythematosus: Case report and literature review	11
The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity	11
Exploration of machine learning methods to predict systemic lupus erythematosus hospitalizations	11
Neuropsychiatric manifestations are associated with increased mortality in Indian patients with lupus: A single centre retrospective observational study	11
Feasibility and preliminary data for a State-wide South Carolina Lupus Registry	11
The association between dietary patterns and a doctor diagnosis of systemic lupus erythematosus: the Adventist Health Study-2	11
Combined treatment of prednisone and hydroxychloroquine may improve outcomes of frozen embryo transfer in antinuclear antibody-positive patients undergoing IVF/ICSI treatment	10
Beyond paraneoplastic neurological syndromes: Anti-neuronal antibodies in neuropsychiatric systemic lupus erythematosus	10
High density lipoprotein influences CD4 T cell proliferation in Systemic Lupus Erythematosus and increases TGF-β1 expression: A potential role in the protection from atherosclerosis and autoimmunity	10
Something new about prognostic factors for lupus nephritis? A systematic review	10
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology	10
Early detect left ventricular subclinical myocardial dysfunction in patients with systemic lupus erythematosus by a left ventricular pressure-strain loop	10
Predictors of damage accrual and its impact on health-related quality of life of thrombotic antiphospholipid syndrome: Independent validation of the damage index for antiphospholipid syndrome (DIAPS)	10
Identification of common MicroRNAs expression signatures in antiphospholipid syndrome and thromboembolic disease: A scoping review	10
Infant feeding experiences of women with systemic lupus erythematosus: A qualitative study	10
Burden of lupus activity on health care resources utilization in Buenos Aires, Argentina	10
Left ventricular diastolic dysfunction and diseases severity contribute to impaired exercise capacity in systemic lupus erythematosus	10
Cognitive impairment in a Colombian cohort of patients with systemic lupus erythematosus: A cross-sectional study	10
Home monitoring of fetal heart rhythm: Lived experiences of women with anti-SSA/Ro52 autoantibodies and their co-parents	10
Telomere length and its association with systemic lupus erythematosus in an Asian population: A Mendelian randomization study	10
Understanding the impact of systemic lupus erythematosus on work amongst South Asian people in the UK: An explorative qualitative study	10
The prognostic value of neutrophile/lymphocyte ratio and serum chemerin to predict maternal-fetal complications in pregnant systemic lupus erythematosus patients	10
Carriage prevalence, serotype distribution, and antimicrobial susceptibility among pneumococcal isolates recovered from adults with systemic lupus erythematosus	9

Fetal proximal and distal limb anomalies following exposure to mycophenolate mofetil during pregnancy: A case report and review of the literature	9
New-onset lupus nephritis associated with COVID-19 infection	9
Clinical disease activity index applicability in lupus arthropathy: Unraveling underdiagnosed joint activity	9
Analysis of 5-year hospitalization data of patients with systemic lupus erythematosus: Damage is a risk factor for frequent and longer stays	9
Expression of caveolin family proteins in serum of patients with systemic lupus erythematosus	9
Unsupervised clustering analysis of data from an online community to identify lupus patient profiles with regards to treatment preferences	9
Correlation between the changes of brain amplitude of low-frequency fluctuation and cognitive impairment in patients with neuropsychiatric lupus	9
Antiphospholipid antibodies and idiopathic infertility	9
The effect of respiratory muscle training on respiratory muscle strength, diaphragm thickness/mobility, and exercise capacity in patients with systemic lupus erythematosus and associated shrinking lun	9
The experience and implications of pain in systemic lupus erythematosus: A qualitative interview study focusing on the patient’s perspective	9
Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohort	9
Does higher quality of care in systemic lupus erythematosus translate to better patient outcomes?	9
Life expectancy and death pattern associated with systemic lupus erythematosus diagnosis in Brazil between 2000 and 2019	9
Elevated apoptosis and abnormal apoptosis signaling of regulatory T cells in patients with systemic lupus erythematosus	9
Navigating the diagnostic maze: A case presentation of C1q vasculitis mimicking hypocomplementemic urticarial vasculitis in a patient with systemic lupus erythematosus	9
Abnormal presentation of pregnancy and postpartum initial-onset systemic lupus erythematosus combined with diffuse alveolar hemorrhage: A case report	9
Association of regulatory T cells with renal outcomes in patients with proliferative lupus nephritis	8
Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark	8
Efficacy and safety of belimumab in systemic lupus erythematosus patients with severe lupus nephritis requiring renal replacement therapy	8
Hydroxychloroquine might reduce risk of incident endometriosis in patients with systemic lupus erythematosus: A retrospective population-based cohort study	8
The correlation between pregnancy, disease activity and adverse pregnancy outcomes in patients with systemic lupus erythematosus	8
Disease features at diagnosis and changes in disease course severity among commercially insured patients with childhood-onset compared with adult-onset systemic lupus erythematosus	8
Polyneuritis cranialis as a unique initial presentation of juvenile systemic lupus erythematosus: Case report	8
Low disease activity state in juvenile-onset systemic lupus erythematosus	8
Systemic lupus erythematosus with hypothermia and Wallenberg’s syndrome as signs of brainstem encephalitis: A grand rounds case	8
Current smoking is related to severe damage in systemic lupus erythematosus patients	8
Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients	8
Patient experiences and strategies for coping with SLE: A qualitative study	8
Dissociation in SLE: A part of lupus fog?	8
EBV load is associated with cfDNA fragmentation and renal damage in SLE patients	8
Mental health in patients with rheumatic diseases related to COVID-19 pandemic: Experience in a tertiary care center in Latin America	8
Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus	8
Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of systemic lupus erythematosus in Canada: A scoping review	8
Mortality in patients with systemic lupus erythematosus: A meta-analysis of overall and cause-specific effects	7
Assessment of the association between TNIP1 polymorphism with clinical features and risk of systemic lupus erythematosus	7
Long COVID in patients with systemic lupus erythematosus: A case-control study	7
Multidisciplinary approach to lupus nephritis: Clinical pearls, pitfalls, and positioning of newly-approved agents	7
Childhood-onset systemic lupus erythematosus: A descriptive and comparative study of clinical, laboratory, and treatment characteristics in two populations	7
Macrophage activation syndrome as a presenting feature in juvenile systemic lupus erythematosus	7
Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life	7
Refractory lupus hepatitis successfully treated with telitacicept who failed to belimumab: A case report and literature review	7
Sociodemographic profiles and organ damage accural in the Black Women’s Experience Living with Lupus study	7
Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus	7
Investigating the role of IL-6 in the pathogenesis of systemic lupus erythematosus: Insights from bone marrow mesenchymal stem cells	7
Literature review of lupus nephritis From the Arabian Gulf region	7
The performance of the 2019 EULAR/ACR classification criteria in childhood-onset systemic lupus erythematosus	7
Examination of antinuclear antibody staining patterns and titers in patients with childhood-onset systemic lupus erythematosus	7
Pediatric onset lupus nephritis in western India—is it different from the rest of the country?	7
The relation of CD4+CD25+Foxp3+ regulatory T cells concentration with disease activity and damage index in systemic lupus erythematosus	7
Impact of miRNA-binding site polymorphisms in STAT3 gene on occurrence and clinical characteristics of systemic lupus erythematosus	7
Detection of genetic mutations underlying early-onset systemic lupus erythematosus	7
Gut microbiome composition and intestinal immunity in antiphospholipid syndrome patients versus healthy controls	7
Severe thrombotic events associated with pre-procedural interruption of anticoagulation in systemic lupus erythematosus with secondary antiphospholipid syndrome: Cases and literature review	7
Psychiatric comorbidities in patients suffering from systemic lupus erythematosus admitted to a tertiary care hospital in Northern India	7
Belimumab in subacute cutaneous lupus erythematosus	7
Neonatal lupus erythematosus: 24 years of experience from a tertiary centre at Chandigarh, North India	7
Cell activation, PD-1 expression and in vitro cytokine production in patients with juvenile systemic lupus erythematosus	7
Systemic lupus erythematosus on social networking sites: Friends or foes?	7
Integrating spiritual disposition intervention into behavioral medicine: A case report on systemic lupus erythematosus from India	6
A qualitative investigation of the experiences of patients living with antiphospholipid antibodies	6
Evaluation of self-report screening measures in the detection of depressive and anxiety disorders among children and adolescents with systemic lupus erythematosus	6
Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis	6
Clinical features and two-year outcomes in systemic lupus erythematosus patients with heart failure and reduced, mid-range and preserved ejection fractions	6
ASIA syndrome with severe lupus – A case report	6
Utility of pan-immune-inflammation value as a predictor of the prognosis of childhood lupus	6
Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis	6
Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review	6
Health-related quality of life, fatigue and health utilities in lupus nephritis: A systematic literature review	6
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)	6
The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome	6
Silicone breast implants and Lupus	6
What you need to know about migraine in Hughes syndrome patients	6
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome	6
Social impact of disease parameters and damage accrual in adult Brazilian patients with childhood-onset Systemic Lupus Erythematosus	6
Depression in systemic lupus erythematosus: A manifestation of microcirculation dysfunction?	6
Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance	6
Factors detrimental to work productivity and daily activities in systemic lupus erythematosus patients – Analysis of the German LuLa study	6
16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends	6
Considering belimumab during pregnancy: A more viable option over time	6
Nocardiosis in systemic lupus erythematosus patients treated with rituximab: Report of two cases and systematic review of literature	6

The impact of white matter brain lesions on processing speed deficits in systemic lupus erythematosus patients	6
Skin and beyond: Demographics, clinical features and systemic involvement of cutaneous lupus erythematosus in Pakistani population	6
Repeat kidney biopsy findings of lupus nephritis patients in clinical remission treated with Mycophenolate associated with Belimumab or Mycophenolate plus standard of care therapy. A “post-hoc” analys	6
2019 ACR/EULAR classification criteria and therapy in predicting organ damage accrual in patients with childhood-onset systemic lupus erythematosus: A retrospective study over the last 29 years	6
Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort	6
Telehealth-supervised exercise in systemic lupus erythematosus: A pilot study	6
Association between serum uric acid level and systemic lupus erythematosus kidney outcome: An observational study in Southern Chinese population and a meta-analysis	6
DNA methylation alterations in systemic lupus erythematosus: A systematic review of case-control studies	6
The relationship between the modified National Institute of Health activity and chronicity scoring system, and the long-term prognosis for lupus nephritis: A retrospective single-center study	6
Alterations of the microbiome across body sites in systemic lupus erythematosus: A systematic review and meta-analysis	6
Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study	6
Uncommon toxic epidermal necrolysis -like presentation of cutaneous lupus erythematosus: A series of 6 cases	6
Systemic lupus erythematosus in children and adults: A retrospective study in Brazilian patients	6
Significant association of functional variants in the promoter sequence of IL18 with disease susceptibility and systemic lupus erythematosus clinical parameters	6
SLE patient satisfaction with care in Jordan: A single-center study	6
Idiopathic intracranial hypertension as the initial presenting manifestation of systemic lupus erythematosus in a child	6
Association of juvenile systemic lupus erythematosus and retinal vasculitis: Genetic aspects	5
A tissue-selective estrogen complex as treatment of osteoporosis in experimental lupus	5
Illness experience and authorship of life in a “transplanted person” with Lupus: A DIPEx perspective	5
Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset	5
Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus	5
Beneficial effects associated to a healthy lifestyle in systemic lupus erythematosus: A cross-sectional study	5
Naomi Rothfield, MD, MACR 1929-2023	5
Assessment of bidirectional relationships between systemic lupus erythematosus and anxiety disorder: A two-sample Mendelian randomization study	5
2019 EULAR/ACR classification criteria for SLE score predicts future lupus hospital admission and costs	5
Exploring gastrointestinal manifestations in childhood onset systemic lupus erythematosus - Insights from a multicenter study	5
Pristane cadmium chloride nanoemulsion accelerates the onset of systemic lupus erythematosus in a C57BL/6 mouse model	5
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study	5
Electronic health record data use in the assessment of quality indicators for glucocorticoid osteoporosis screening in systemic lupus erythematosus	5
Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome	5
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score	5
Skin erythematous migrant lesions consistent with histologically confirmed dermal arteriolar thrombosis connected to APS	5
An ecological approach to understanding and addressing health inequities of systemic lupus erythematosus	5
Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis	5
Diffuse cerebral edema with leukoencephalopathy revealing systemic lupus erythematosus: A case report and review of literature	5
Safety of tacrolimus use during pregnancy and related pregnancy outcomes in patients with systemic lupus erythematosus: A retrospective single-center analysis in Japan	5
Identification of IFITM3 as a diagnostic biomarker of systemic lupus erythematosus and its association with disease activity based on multi-omics and experimental verification	5
Dr. Eng Meng Tan August 26, 1926 - March 9, 2024 La Jolla, California	5
Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study	5
Psychometric properties evaluation of the Persian version of the self-report outcome scale for lupus disease Lupus_PRO version 1.7	5
Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients	5
Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile	5
Possible relationship between hydroxychloroquine and electrocardiographic and echocardiographic abnormalities in patients with inflammatory rheumatic diseases––a monocentric study	5
Glucocorticoid-free remission in patients with SLE in the era of biologics: Immune complex disease is likely to benefit from current medications	5
Evaluating the risk of QTc prolongation associated with hydroxychloroquine use with antidepressants in lupus patients with fibromyalgia	5
The effectiveness of telitacicept in patients with systemic lupus erythematosus: A retrospective, real-world study	5
Letter re: Lupus erythematosus masquerading as acneiform lesions: two cases and review of the literature	5
Treatment outcomes in refractory lupus nephritis: Data from an observational study	5
Efficacy of Telitacicept in a systemic lupus erythematosus patient with suboptimal response to Belimumab: A case report	5
Teriflunomide normalizes anti-anxiety effect in anti-ANXA2 APS mice model teriflunomide in anti-ANXA2 mice model	5
Factors affecting discrepancies in disease activity evaluation between patients and physicians in systemic lupus erythematosus-The importance of symptoms such as fatigue	5
Reversibility of pulmonary hypertension in systemic lupus erythematosus after induction immunosuppressive therapy: An inflammatory manifestation?	5
Hematologic manifestations of juvenile systemic lupus erythematosus: An emphasis on anemia	5
The first use of “lupus” as a disease	5
Withdrawal of “Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study”	5
Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study	5
Assessment of renal response in Tunisian patients with proliferative lupus nephritis under three different induction immunosuppressive agents: A prognostic retrospective study	5
The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study	5
Association of Human Leucocyte Antigen Class II, with viral load and immune response to Epstein–Barr virus in adult and pediatric Systemic lupus erythematosus patients	5
Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab	4
Are autoimmune diseases autoinflammatory: Is it time to change the paradigm?	4
Nutritional, biochemical, and clinical determinants of hyperuricemia in systemic lupus erythematosus patients: Relationship with clinical and renal disease activity	4
Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study	4
Prevalence of cognitive impairment and cognitive improvement in patients with systemic lupus erythematosus during a 6-month follow-up study	4
Social media as source of information for Spanish-speaking patients with systemic lupus erythematosus	4
Refractory antiphospholipid antibody syndrome–induced thrombocytopaenia successfully treated with belimumab	4
Clinical algorithm model based on cfDNA to predict SLE disease activity	4
Exploring the role of LIAS-related cuproptosis in systemic lupus erythematosus	4
Lupus, vaccinations and COVID-19: What we know now	4
Cardiovascular disease risk perceptions and influencing factors among Chinese systemic lupus erythematosus patients	4
Health care practitioners’ confidence assessing lupus-related rashes in patients of color	4
Addition of constitutional symptoms to the SLEDAI-2K improves overall disease activity assessment: A pilot study	4
Avoiding misclassification of thrombotic primary antiphospholipid syndrome as systemic lupus erythematosus (SLE): What are the best-performing SLE classification criteria?	4
Evaluation of the interaction between anti-apoptotic Bcl-2 protein family mRNA expression and autophagy gene Bcl-1 expression in Egyptian SLE patients	4
Advances in the study of exosome-derived miRNAs in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus	4
Systemic lupus erythematosus patients have a distinct structural and functional skin microbiota compared with controls	4
Maternal and fetal health outcomes in systemic lupus erythematosus pregnancies in the Emirati population: A comparative study	4
Development and psychometric properties of the Reproductive Health Assessment in Systemic Lupus Erythematosus: Mixed-Methods study	4
Clinical significance of serum soluble scavenger receptor CD163 in patients with lupus nephritis	4
Prevalence of migraine in systemic lupus erythematosus: A meta-analysis	4
Erosive arthritis in systemic lupus erythematosus: not only Rhupus	4
Lupus and SARS-CoV-2: What have we learned after the pandemic?	4
ARID5B rs10821936 and rs10994982 gene polymorphism and susceptibility to juvenile systemic lupus erythematosus and lupus nephritis	4
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome	4
Impact of online health information-seeking behavior on shared decision-making in patients with systemic lupus erythematosus: The TRUMP2-SLE project	4
Predicting kidney outcomes among Latin American patients with lupus nephritis: The prognostic value of interstitial fibrosis and tubular atrophy and tubulointerstitial inflammation	4
Kidney transplantation outcomes in lupus nephritis: A 37-year single-center experience from Latin America	4
The efficacy of induction treatment in Thai patients with lupus nephritis: Observational cohort analysis	4
Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel	4
Thanks to Reviewers	4
Pulmonary involvement: A potential independent factor for quality of life in systemic lupus erythematosus	4
Aggravation of discoid lupus erythematosus in a patient with psoriasis and psoriatic arthritis during treatment of secukinumab: A case report and review of literature	4
Systemic lupus erythematosus and toll-like receptor 9 polymorphisms: A meta-analysis of genetic association studies	4
Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis	4
Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications	4